With over 27 years of experience, EPI-Q assists Fortune 100 biopharmaceutical and medical device firms in demonstrating the clinical and economic value of their products. Their multidisciplinary team of experts generates, analyzes, and publishes data to establish the true value of healthcare innovation throughout a product's lifecycle. EPI-Q's services include developing evidence and value propositions to support product commercialization, facilitating market access, and optimizing pricing and reimbursement. Their international network allows them to tailor and execute global strategies, plans, and research effectively and efficiently.